Hashem Haghdoost Yazdi (Hashem Haghdoost-Yazdi)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Neurological research

Metabolic brain disease

Biological trace element research

Basic and clinical neuroscience

Qazvin University of Medical Sciences

Shahid Beheshti University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Qazvin University of Medical Sciences Nov 20 2005

Iran

associate professor :: Physiology and cellular and molecular research center

Education History

Shahid Beheshti University of Medical Sciences Feb 18 2000 - Oct 20 2005

Iran

PHD :: Physiology

Tehran University of Medical Sciences Sep 17 1996 - Nov 18 1999

Iran

MSC :: Physiology

Publications

Seyed Amir Farzam, Shahram Darabi, Hashem Haghdoost Yazdi, Yasamin Zaferani
Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease. Neurological research 46 (8) (2024)
Mohammad Sophiabadi, Nafiseh Rastgoo, Hashem Haghdoost Yazdi
Retraction Note: Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease. Biological trace element research (2024)
Seyed Amir Farzam, Shahram Darabi, Hashem Haghdoost Yazdi, Yasamin Zaferani
Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease. Neurological research 46 (8) (2024)
Seyed Amir Farzam, Shahram Darabi, Hashem Haghdoost Yazdi, Yasamin Zaferani
Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease. Neurological research (2024)
Ali Sarbazi-Golezari, Hashem Haghdoost Yazdi
Retraction Note: Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta. Metabolic brain disease (2023)
Ali Sarbazi-Golezari, Hashem Haghdoost Yazdi
Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta. Metabolic brain disease (2021)
Roghaieh Razaghi, Hossein Piri, Hanieh Jafari, Nafiseh Rastgoo, Mohammad Ali Hosseini, Hashem Haghdoost Yazdi
Evaluation of the Association Between Serum Levels of Testosterone and Prolactin With 6- Hydroxydopamine-Induced Parkinsonism in Male Rats. Basic and clinical neuroscience 12 (4) (2021)
Mohammad Sophiabadi, Nafiseh Rastgoo, Hashem Haghdoost Yazdi
Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease. Biological trace element research (2021)
Mohammad Reza Sarukhani, Hashem Haghdoost Yazdi, Gilda Khandan-Chelarci
Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model. Neurochemical research 43 (5) (2018)

Hashem Haghdoost Yazdi.css-eqlu8i{font-size:small;padding-left:4px;} (Hashem Haghdoost-Yazdi)

Publication Activity (10 Years)

Top Topics

Top Venues

Hashem Haghdoost Yazdi (Hashem Haghdoost-Yazdi)